Letters to the Editor
Nivolumab and ipilimumab-induced eosinophilic granulomatosis with polyangiitis in a patient treated with dupilumab
F. Bottazzi1, A. Milanesi2, V. Codullo3, A. Messina4, C. Montecucco5, P. Delvino6
- Department of Internal Medicine and Therapeutics, Università degli studi di Pavia; and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. francesca.bottazzi01@universitadipavia.it
- Department of Internal Medicine and Therapeutics, Università degli studi di Pavia; Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia; and PhD in Experimental Medicine, University of Pavia, Italy.
- Department of Internal Medicine and Therapeutics, Università degli studi di Pavia; and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- Department of Molecular Medicine, University of Pavia, Unit of Anatomic Pathology, IRCCS San Matteo Hospital Foundation, Pavia, Italy.
- Department of Internal Medicine and Therapeutics, Università degli studi di Pavia; and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- School of Medicine, University of Milano-Bicocca, Milan; and IRCCS San Gerardo dei Tintori Foundation, Monza, Italy.
CER18034
2025 Vol.43, N°4
PI 0770, PF 0771
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 39680078 [PubMed]
Received: 03/08/2024
Accepted : 23/09/2024
In Press: 16/12/2024
Published: 08/04/2025
